NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

$42.20

-0.99 (-2.29 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$41.67

Now: $42.20▼

$43.34

50-Day Range

$37.46

MA: $40.30▼

$44.07

52-Week Range

$27.40

Now: $42.20▼

$46.12

Volume726,952 shs

Average Volume441,619 shs

Market Capitalization$2.11 billion

P/E Ratio15.18

Dividend YieldN/A

Beta0.8

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Beat the Market (BTM) Rank^™

4.1 Analyst's Opinion

Consensus Rating
Prestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 1 buy rating, 6 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $71.00, Prestige Consumer Healthcare has a potential upside of 68.2% from its current price of $42.20.
Amount of Analyst Coverage
Prestige Consumer Healthcare has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.8 Community Rank

Outperform Votes
Prestige Consumer Healthcare has received 458 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Prestige Consumer Healthcare has received 350 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Prestige Consumer Healthcare has received 56.68% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote “Outperform” if you believe PBH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Prestige Consumer Healthcare does not currently pay a dividend.
Dividend Growth
Prestige Consumer Healthcare does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Prestige Consumer Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,183,720.00 in company stock.
Percentage Held by Insiders
Only 1.14% of the stock of Prestige Consumer Healthcare is held by insiders.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Prestige Consumer Healthcare are expected to grow by 5.02% in the coming year, from $2.99 to $3.14 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Prestige Consumer Healthcare is 15.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.14.
Price to Earnings Ratio vs. Sector
The P/E ratio of Prestige Consumer Healthcare is 15.18, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 17.29.
Price to Earnings Growth Ratio
Prestige Consumer Healthcare has a PEG Ratio of 3.53. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Prestige Consumer Healthcare has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.62 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Pharmaceutical preparations

Sub-IndustryPersonal Products

SectorConsumer Discretionary

Current SymbolNYSE:PBH

Previous Symbol

CUSIP74112D10

CIK1295947

Webwww.prestigebrands.com

Phone914-524-6800

Debt

Debt-to-Equity Ratio1.50

Current Ratio2.44

Quick Ratio1.67

Price-To-Earnings

Trailing P/E Ratio15.18

Forward P/E Ratio14.11

P/E Growth3.53

Sales & Book Value

Annual Sales$963.01 million

Price / Sales2.19

Cash Flow$3.66 per share

Price / Cash Flow11.52

Book Value$23.38 per share

Price / Book1.80

Profitability

EPS (Most Recent Fiscal Year)$2.96

Net Income$142.28 million

Net Margins14.77%

Return on Equity13.33%

Return on Assets4.35%

Miscellaneous

Employees530

Outstanding Shares50,080,000

Market Cap$2.11 billion

Next Earnings Date8/6/2020 (Estimated)

OptionableOptionable

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PBH shares have increased by 17.5% and is now trading at $42.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Prestige Consumer Healthcare.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Prestige Consumer Healthcare.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) announced its earnings results on Thursday, May, 7th. The company reported $0.82 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.74 by $0.08. The firm had revenue of $251.20 million for the quarter, compared to analyst estimates of $239.65 million. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. The company's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period last year, the company posted $0.72 earnings per share. View Prestige Consumer Healthcare's earnings history.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its first quarter earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus estimate of $0.69. The company issued revenue guidance of ~$220 million or more, compared to the consensus revenue estimate of $232.21 million.

What price target have analysts set for PBH?

7 brokerages have issued 1-year target prices for Prestige Consumer Healthcare's shares. Their forecasts range from $43.00 to $91.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $71.00 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price. View analysts' price targets for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

News headlines about PBH stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a news impact score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutPrestige Consumer Healthcare.

Who are some of Prestige Consumer Healthcare's key competitors?

Some companies that are related to Prestige Consumer Healthcare include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Inter Parfums (IPAR), Medifast (MED), Revlon (REV), Veru (VERU) and Nature's Sunshine Products (NATR). View all competitors.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), GW Pharmaceuticals PLC- (GWPH), Johnson & Johnson (JNJ), TG Therapeutics (TGTX), Flexion Therapeutics (FLXN), Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T) and Thermo Fisher Scientific (TMO).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:

Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
Ms. Christine Sacco, Chief Financial Officer (Age 43)
Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
Mr. Jeff Zerillo, Sr. VP of Operations

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (12.66%), Champlain Investment Partners LLC (4.92%), Wells Fargo & Company MN (4.01%), JPMorgan Chase & Co. (3.82%), State Street Corp (3.55%) and Acadian Asset Management LLC (2.99%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors. View institutional ownership trends for Prestige Consumer Healthcare.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., BlackRock Inc., JPMorgan Chase & Co., First Manhattan Co., Invesco Ltd., Massachusetts Financial Services Co. MA, The Manufacturers Life Insurance Company , and Morgan Stanley. View insider buying and selling activity for Prestige Consumer Healthcare.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, AQR Capital Management LLC, Grantham Mayo Van Otterloo & Co. LLC, Monarch Partners Asset Management LLC, Champlain Investment Partners LLC, Jennison Associates LLC, Acadian Asset Management LLC, and Citigroup Inc.. View insider buying and selling activity for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $42.20.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $2.11 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff